PEAK6 Group’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
$8.53M Sell
100,000
-29,400
-23% -$2.41M 0.04% 522
2018
Q1
$10M Buy
129,400
+49,300
+62% +$3.97M 0.04% 451
2017
Q4
$6.76M Sell
80,100
-144,800
-64% -$12.3M 0.03% 669
2017
Q3
$19.2M Buy
224,900
+86,400
+62% +$7.09M 0.1% 210
2017
Q2
$11.4M Buy
138,500
+100,000
+260% +$8.16M 0.07% 323
2017
Q1
$3.24M Sell
38,500
-20,800
-35% -$1.67M 0.03% 812
2016
Q4
$4.36M Sell
59,300
-190,800
-76% -$14.2M 0.03% 786
2016
Q3
$20.1M Buy
250,100
+21,300
+9% +$1.7M 0.15% 127
2016
Q2
$18M Sell
228,800
-30,600
-12% -$2.3M 0.14% 138
2016
Q1
$18.7M Sell
259,400
-362,400
-58% -$27.4M 0.15% 136
2015
Q4
$52.4M Buy
621,800
+72,600
+13% +$6.02M 0.35% 19
2015
Q3
$46M Buy
549,200
+228,400
+71% +$19.3M 0.24% 50
2015
Q2
$26.8M Buy
320,800
+268,300
+511% +$20.4M 0.16% 110
2015
Q1
$3.81M Buy
52,500
+17,100
+48% +$1.22M 0.03% 838
2014
Q4
$2.44M Sell
35,400
-121,800
-77% -$8.22M 0.02% 1144
2014
Q3
$10.2M Buy
157,200
+94,700
+152% +$6M 0.08% 320
2014
Q2
$3.89M Buy
62,500
+11,500
+23% +$686K 0.04% 669
2014
Q1
$3M Sell
51,000
-201,600
-80% -$11.3M 0.03% 963
2013
Q4
$12.9M Buy
252,600
+141,400
+127% +$7.08M 0.09% 230
2013
Q3
$2.8M Buy
111,200
+39,400
+55% +$2.06M 0.02% 1251
2013
Q2
$3.53K Buy
+71,800
New +$3.91M 0.01% 1036

Other funds holding LLY

PEAK6 Group's LLY Position: Q2 2018 in Review

PEAK6 Group sold out of Eli Lilly (LLY) in Q2 2018, closing a stake of 16,921 shares — an estimated $1.39M sold.

PEAK6 Group first reported a position in LLY in Q2 2013 and held it in 12 quarters. The position peaked at $8.74M in Q3 2015. 1,368 funds tracked by Wall St. Rank hold LLY as of Q2 2018.

  • PEAK6 Group reported no remaining Eli Lilly position as of Q2 2018 after selling out during the quarter.
  • PEAK6 Group sold 16,921 Eli Lilly shares in Q2 2018, an estimated $1.39M.
  • PEAK6 Group first reported a position in Eli Lilly in Q2 2013 and held it in 12 quarters.
  • PEAK6 Group's Eli Lilly position peaked at $8.74M in Q3 2015.
  • 1,368 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2018.

Based on PEAK6 Group's 13F filing for Q2 2018, filed 15 Aug 2018.